bepecin equine bpc 157 paper performance genes and the future of doping in horseracing - Wilkin - 2017 - Drug Testing and Analysis BPC-157: Experimental Peptide Creates Risk
Description
No recycled or generic COAs

Trust the process

The results were expressed as a fold change in comparison with control samples (expressed as percentages), and the range between 70% and 130% was considered biological variability (Maul, 2008
We are committed to providing high quality products to improve human health and achieve sustainable growth for the company The company specializes in the production and research of various ingredients, and we pride ourselves on achieving delivery goals that are difficult for other companies to achieve Our research and development resources and production facilities as well as analytical instruments are advanced and leading-edge, allowing us to achieve production and precision delivery in the milligram to tonnage range, in compliance with ISO9001 and GMP standards
